The DigniCap Scalp Cooling System has been used around the world since 2001. In 2015, after a multi-center clinical trial, DigniCap became the first scalp cooling system to receive FDA clearance in the
United States.


DigniCap offers patients the ability to reduce hair loss from certain chemotherapy treatments and is FDA cleared for patients with solid tumors.

The DigniCap Scalp Cooling System consists of a computerized cooling unit managed through a touch screen display and an attached cooling cap. Temperature regulated coolant continuously circulates though specially designed channels in the cooling cap. The ability to maintain continuous, direct contact between the cooling cap and scalp for a consistent treatment temperature is a key factor in the effectiveness of DigniCap.

There are 2 models of The DigniCap Scalp Cooling System, the NEW DigniCap Delta and DigniCap C3. Both systems provide effective scalp cooling, but the machine, caps and business models are different.

CLICK HERE for more information on the NEW DigniCap Delta –  FDA cleared 2019, CE Mark 2019

CLICK HERE for more information on DigniCap C3 – CE Mark 2001, FDA cleared 2015

Please note that the content of this website is not intended as professional medical or healthcare advice and should not be construed as a substitute for professional healthcare advice, or services from a qualified professional healthcare provider familiar with your unique situation. This content is intended solely as a general product and corporate information.

Dignitana AB
Traktorgränden 3
226 60 Lund, Sweden
+46 46 16 30 90

10925 Estate Lane, Suite 185
Dallas, TX 75238
+1 469-917-5555

Dignitana S.r.l.
Corso di Porta Nuova, 46
20121 Milan, Italy